Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Lonza Group Stock News

LZAGYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$61.08

0.400.66%

Pre-Market: Mar 11, 8:09 AM EDT

Lonza Group (LZAGY) Forecast

News

Earnings Lonza Group (LZAGY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Lonza Group Stock News | OTC:LZAGY | Benzinga

Get the latest news on Lonza Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Lonza Group performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, December 12, 2024

Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development
Vandana Singh

Wednesday, March 20, 2024

Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Vandana Singh

Wednesday, June 22, 2022

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
Vandana Singh

Wednesday, June 02, 2021

Moderna, Lonza Team Up To Produce New Drug Substance for COVID-19 Vaccine Doses
Vandana Singh

Thursday, April 29, 2021

Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
Vandana Singh

Wednesday, April 14, 2021

aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810
Vandana Singh

Friday, March 12, 2021

Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza
Vandana Singh

Tuesday, February 23, 2021

Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021
Benzinga Insights
JP Morgan Upgrades Lonza Group to Overweight
Benzinga Newsdesk

Tuesday, November 10, 2020

KeyBanc Initiates Coverage On Lonza Group wit...
Benzinga Newsdesk

Monday, July 27, 2020

Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development
Shivdeep Dhaliwal

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Thursday, February 13, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Wednesday, February 12, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin

Tuesday, February 11, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Wednesday, January 22, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin

Tuesday, January 21, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Thursday, January 16, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Thursday, October 17, 2019

The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
Shanthi Rexaline
Mesoblast, Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast's Potential First United States Allogeneic Cell Therapy
Charles Gross

Tuesday, October 08, 2019

The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
Shanthi Rexaline
Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
Charles Gross

Friday, August 09, 2019

A List Of Stocks Reaching New 52-Week Highs
Lisa Levin

Thursday, August 08, 2019

Stocks That Set New 52-Week Highs Thursday
Lisa Levin

Tuesday, July 23, 2019

Stocks that Broke 52-Week Highs Tuesday
Lisa Levin

Wednesday, June 19, 2019

Gamida Cell,Lonza Establish Commercial Manufacturing Agreement for Omidubicel
Charles Gross

Tuesday, July 17, 2018

Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines
Benzinga

Thursday, April 14, 2016

Benzinga's M&A Chatter for Wednesday April 13, 2016
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved